← Back to Clinical Trials
Recruiting NCT06838598

NCT06838598 Structural and Microbiological Characterization of Arterial Catheter Biofilm in ICU's Patients Using Optical Coherence Tomography

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06838598
Status Recruiting
Phase
Sponsor Centre Hospitalier William Morey - Chalon sur Saône
Condition Biofilms
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2024-06-03
Primary Completion 2027-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
OCT-BIO-KTA cohort

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2024-06-03 with a primary completion date of 2027-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

29.3% of bacteremias in intensive care units (ICU) are linked to vascular devices, including 7.7% to arterial catheters, with an influence on both morbility and mortality. It is now accepted that biofilm as a role on bacterial development on inner surface of vascular devices but there is yet a lack of clinical relevant data documenting a causal relation between biofilm formation and bacteremias. The investigators assume that a better structural and microbiological characterization of arterial catheter biofilm in ICU patients could help preventing bacteremias or have a more specific treatment when it appears.

Eligibility Criteria

Inclusion Criteria: * Patient or relative informed of the study and having declared their non-objection * Patient over 18 years old * Patient hospitalized in ICU with an arterial catheter Exclusion Criteria: * Patient unable to express consent * Patient whose collection of the arterial catheter is impossible or for whom storage at 4°C is impossible * Patient with arterial catheter removed outside the usual procedure of the ICU * Patient admitted in ICU with an arterial catheter already in place

Contact & Investigator

Central Contact

Florian PERRAUD

✉ florian.perraud@ch-chalon.fr

📞 06 78 58 85 19

Frequently Asked Questions

Who can join the NCT06838598 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Biofilms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06838598 currently recruiting?

Yes, NCT06838598 is actively recruiting participants. Contact the research team at florian.perraud@ch-chalon.fr for enrollment information.

Where is the NCT06838598 trial being conducted?

This trial is being conducted at Dijon, France, Mâcon, France.

Who is sponsoring the NCT06838598 clinical trial?

NCT06838598 is sponsored by Centre Hospitalier William Morey - Chalon sur Saône. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology